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Summary
This article reviews the basic theoretical background to
diffusion tensor imaging (DTI) and some of the common
clinical applications of DTI as of today such as cerebral
ischaemia, brain maturation, ageing and cognitive
impairment. The value of DTI in the work-up of brain
tumours, as a tool in the differentiation of radiation injury
versus recurrent tumour, and in brain injury is reviewed.
The potential use of this technique in diseases such as
epilepsy, multiple sclerosis, Alzheimer’s disease and meta-
bolic disorders is also briefly reviewed.
Introduction and background to diffusion tensor
imaging
Diffusion-weighted imaging (DWI) is a well-established
method that is implemented as a part of routine protocol at
many institutions around the world. DWI measures the
diffusivity of visible water molecules (1) and the principles
for the measurement of diffusion with magnetic resonance
imaging (MRI) are well described (2, 3). DWI has shown to
be a very useful tool for detection of early signs of isch-
aemia (4, 5), but is also increasingly used in the evaluation
of other brain diseases, e.g. multiple sclerosis (6–8), trauma
(9, 10), brain tumour (11, 12), and hypertensive
encephalopathy (13, 14), among others.
Further improvements in the imaging of water diffusion
have been done by the recent development of the more
complex diffusion tensor imaging (DTI) which allows direct
examination, in vivo, of some aspects of tissue microstruc-
ture. DTI yields quantitative measures reflecting the
integrity of white matter fibres tracts by taking advantage
of the intrinsic properties of directionality of water
diffusion in human brain tissue. The diffusion of water
molecules is characterized by Brownian motion. When
water molecules are unconstrained, the direction of motion
of a given molecule is random. The displacements of water
molecules over time are described by a Gaussian distribu-
tion. The diffusion is called isotropic when the motion is
equal and unconstrained in all directions. However, the
microstructure of brain tissue forms physical boundaries
that limit the Brownian motion of water molecules,
resulting in a restriction of the total amount of diffusion.
In microstructures like the white matter fibres, the diffusion
of water molecules will be relatively more restricted
perpendicular than parallel to the microstructural bound-
aries and the diffusion is called anisotropic (15).
In plain DWI MRI, diffusion is described using a scalar
parameter – the diffusion coefficient D. In tissues, such as
grey matter, where the measured apparent diffusivity is
merely isotropic, it is sufficient to describe the diffusion
characteristics with a single scalar apparent diffusion
coefficient (ADC). In the presence of anisotropy, the
diffusion can no longer be characterized by a single scalar
coefficient but requires a tensor D, which fully describes
the mobility of the molecules along each direction and the
correlation between these directions. The mathematical
construct used to characterize anisotropic Gaussian diffu-
sion is a second-order diffusion tensor (16). As the tensor is
symmetric, at least six unique elements are required to
fully characterize the tensor (3). The tensor can be
diagonalized such that only three non-zero elements (k1,
k2, and k3) remain along the diagonal. These elements are
known as the eigenvalues. Each eigenvalue is associated
with an eigenvector (e1, e2 and e3), where the largest of the
three eigenvalues (k1) corresponds to the primary eigen-
vector e1 of the diffusion tensor and describes the principal
direction of the diffusion at that point, whereas the two
minor eigenvalues, k2 and k3, give the strength of
diffusion along directions orthogonal to the preferred
direction.
The main artefacts in obtaining DTI data are the usual
artefacts and problems associated with acquiring the DWI
data from which the diffusion tensor is estimated or
measured. Artefacts such as misregistration of the data due
to eddy currents, ghosting due to motion artefacts, and
signal loss due to susceptibility variations. Hardware issues
such as background gradients, gradient non-linearity and
miscalibration also have to be taken in consideration.
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However, improvements in image resolution and reduction
of distortion have been made using motion-corrected
multishot EPI PROPELLER and SENSE-EPI techniques
(17, 18).
Diffusion tensor measurements result in a rich data set.
Metrics of diffusion anisotropy can be measured in
different ways by applying simple or more complicated
mathematical formulas and recalculations using the under-
lying eigenvectors (3, 4, 16, 19).
A common way to summarize diffusion measurements
in the DTI is the calculation of parameter for the overall
diffusivity and another parameter that reflects anisotropy.
The ADC serves for overall diffusivity and is derived from
the trace of the diffusion tensor. Anisotropy is represented
by the fractional anisotropy (FA) or alternatively the
relative anisotropy (RA). The FA is a measure of the
portion of the magnitude of the diffusion tensor due to
anisotropy. The RA is derived from a ratio between the
anisotropic portion of the diffusion tensor and the isotopic
portion. Another commonly used value is the volume ratio
(VR) which expresses the relationship between the diffu-
sion ellipsoid volume and the volume of a sphere with
radius {k} (20). From previous work it is known that both
the water ADC and the diffusion anisotropy, differ
markedly between paediatric brain and adult brain, and,
also, both parameters vary with increasing age and
location in the brain (21–23).
The differences between these measurements lie in their
sensitivity to anisotropy: FA is more sensitive for low
anisotropy values, whereas VR is sensitive to high values of
diffusion anisotropy, and RA scales linearly for different
levels of anisotropy (3). Both FA and RA are 0.0 for a
purely isotropic medium. For higher symmetric anisotropic
medium FA tends towards 1, while RA tends towards 2.
Both FA and RA maps can be presented as grey scale
images for the purpose of evaluation. As for VR, the range
is from 1 (isotropic diffusion) to 0, therefore, some authors
prefer to use (1-VR). In contrast to aforementioned
measurements which all represent intravoxel anisotropy,
the lattice anisotropy index – another way to evaluate
diffusion – measures the intervoxel anisotropy. The lattice
measures of diffusion anisotropy allow neighbouring voxels
to be considered together in a region of interest, without
losing anisotropy effects that result from different fibre
orientations across voxels (20).
DTI allows us to look at the anisotropic diffusion within
the white matter tracts but is limited in demonstrating the
spatial, directional diffusion anisotropy. Therefore, new
and or more sophisticated methods to demonstrate diffu-
sion directions such as colour coding and fibre tracking
have been proposed (24–27).
By choosing the eigenvector associated with the largest
eigenvalue, the principal diffusion direction of the brain
structure to be examined can be encoded with colour,
resulting in colour-coded maps or directionally encoded
FA maps (DEC FA maps). In these colour-encoded maps
the fibres have been given different colours (red, green and
blue) depending on their different diffusion directions (24)
(Fig. 1). The magnitude of the anisotropy, such as FA, can
be used as an illumination factor of the calculation of a
directionally encoded colour image (24).
In fibre tractography, or fibre tracking, white matter
tract directions are mapped under the assumption that in
each voxel a measure of the local fibre orientation is
measured through DTI. The task of tractography is to
sensibly assign mathematical associations between adjacent
voxels based on eigenvalue and eigenvector information.
In DT-MRI tractography it is assumed that the eigenvec-
tor associated with the largest eigenvalue is aligned with
the direction of the fibre bundle (25–28).
There are several problems and pitfalls associated with
the attempts to evaluate the fibre tract tractography
quantitatively. First, all of the usual artefacts and problems
associated with DWI can adversely affect fibre tracking –
artefacts such as misregistration of DWI caused by eddy
currents, ghosting due to motion artefacts, and signal loss
due to susceptibility variations can all affect the computed
tractography (27). Interaction between vectors in the places
where the fibres are crossing or ‘kissing’ or where they
j Fig. 1. Normal. A 32-year-old healthy male. Normal T2-
weighted image (a), apparent diffusion coefficient (ADC)
map (b), fractional anisotropy (FA) map (c), and colour-
coded FA map (d). On the FA map the highly directional
white matter structures are clearly seen (c). On the colour-
coded FA map the fibres have been given different colours:
blue for superior-inferior, green for anterio-posterior, and red
for left to right, depending on their direction of diffusion (d).
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branch or merge poses additional problems. The last
problem is that there is no gold standard for in vivo
tractography.
As fibre tracking requires more extensive computer
calculations and manpower than DWI or the more
complex DTI it remains more of a research instrument
and has, to date, no or very limited clinical application.
However, it seems most likely that diffusion tensor MRI
fibre tractography will improve our understanding of brain
pathology, especially that of white matter abnormalities.
Possible future applications include the evaluation of these
parameters with closed head injury and stroke, and even
the evaluation of peripheral nerve injuries. Fibre tracking
can be used in conjunction with functional MRI (fMRI) to
analyse the anatomical connections and functional path-
ways for diagnostic purpose and in pre-surgical planning
(26).
Clinical applications
While DWI-MRI has several clinical applications and is
routinely used in stroke work-up, DTI is still used pri-
marily in research and not as routine examination at most
institutions. Increasing number of reports is trying to
demonstrate the value of DTI as a tool for evaluation of
different entities in the brain. The following text reviews
some of the clinical areas in which DTI has shown to be of
interest.
DTI in cerebral ischaemia, leucoaraiosis and wallerian
degeneration
With cerebral ischaemia, a decrease in cerebral blood flow
below 10–15 ml/100 g/min leads to increased volume of
intracellular water. This influx of water from the extra-
cellular compartment causes the cells to swell, which
manifests as cytotoxic oedema. With conventional MR
technique, the acute stage of ischaemia is poorly assessed
and the extent of the ischaemic parenchymal tissue can
only be demonstrated at a later stage when the vasogenic
oedema is present. DWI and DTI have been extensively
used to reliably detect hyperacute ischaemic brain injury
while the conventional MRI is still normal (1, 29–31). Both
DWI and DTI also make it possible to distinguish the acute
from the chronic in the course of ischaemic changes, which
may have impact on treatment. In the acute phase, ADC is
initially reduced by 30–50% within 30 min after the onset
of focal ischaemia (29–32), and is more severely reduced in
the white matter compared to the grey matter during acute
and early subacute infarcts (33, 34). With ischaemic brain
trauma, DTI parameters, such as the Dav (equivalent to
ADC), initially decrease but subsequently increase and
become higher than normal values. In fact, these values
remain elevated in the chronic phase of injury (35). In a
short interval between decreased ADC values and the
subsequently increased ADC values there is a short time
period during which the values are normal, a process re-
ferred to as pseudonormalization. Studies have indicated
that this pseudonormalization occurs approximately 9 days
after a cerebral stroke in adults, and in newborns,
approximately 7 days after injury (35). In addition to the
changes in the ADC values, an acute elevation in FA has
been observed in ischaemic white matter but not in isch-
aemic grey matter (36). This acute elevation is followed by
a marked reduction in FA during the chronic phase (36).
These described changes are believed to be due to loss of
organization in normal structures when their cytoarchitec-
ture is disrupted.
In contrast to the re-normalization and subsequent
elevation of the ADC values seen in chronic stroke, the
diffusion anisotropy remains significantly reduced in the
infarcted area compared to the homologous contralateral
region of the brain, even 2–6 months after ischaemic
stroke (37). It has been demonstrated that ADC threshold
values are useful in predicting tissue viability and stroke
outcome (33, 38) and it has also been shown that by
combining ADC and anisotropy data it is possible to
evaluate strokes and predict clinical outcome (33).
In this context it has to be born in mind that there are
clinical conditions under which the ADC increases rather
than decreases after an injury. In general, it appears that
ADC decreases immediately after cell injury in the
presence of cytotoxic oedema. However it may be
increased early on under conditions of vasogenic oedema,
for example, in the reversible posterior leucoencephalo-
pathy syndrome (13, 14), or in high-pressure hydroceph-
alus (39).
Leucoaraiosis is a non-specific name describing the
radiological appearance of diffuse changes in the peri-
ventricular white matter seen either on CT or MR images
(40).
Leucoaraiosis appearance may be seen in various
diseases including chronic ischaemia, Alzheimer’s disease,
and CADASIL (cerebral autosomal dominant arteriopathy
with subcortical infarcts and leucoencephalopathy); histo-
pathological findings of axonal loss and proliferation of
glial cells have been reported in leucoaraiosis (41, 42). In
patients with ischaemic leucoaraiosis, in areas of increased
signal on T2-weigthed images, DTI showed elevated mean
diffusivity and reduced FA (41). Significant changes in FA
in normal appearing white matter in patients with vascular
dementia have been demonstrated and these changes
correlated with executive dysfunction (43). In addition, the
mean diffusivity observed in leucoaraiosis has shown to be
significantly lower than that observed in a lacunar infarct,
most likely due to proliferation of glial tissue in leucoarai-
osis, which interferes with water diffusion (44).
Wallerian degeneration (WD) is described as antegrade
degeneration of axons and their myelin sheaths secondary
to proximal axonal injury or cell death, and is most
commonly involving the corticospinal tracts, secondary to
ipsilateral cerebral infarction.
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It has been shown that DTI is more sensitive than T2-
weighted imaging in detecting WD (45). That investigation
demonstrated that diffusion anisotropy is reduced both in
the primary lesion and in the areas of WD, whereas the
ADC is only slightly increased in WD but is markedly
increased in primary stroke lesions (45). This means that
ADC may have the potential to distinguish primary stroke
lesions from areas of WD (45).
DTI in the developing brain, brain maturation and ageing
Several challenges exist for the application of DTI in the
developing human brain. The value for the water ADC
and diffusion anisotropy differs markedly between the
paediatric and the adult brain and both values also vary
with age (21–23). However, similar MR pulse sequences
and post-processing methods are used for both infant and
adult human brain DTI with the exception of the b-value
which is typically chosen in the order of 1000 mm2/s for
adults and in the order of 700–800 mm2/s for infants.
Significantly higher ADC and lower FA in neonates
have been found compared with those in adults (46). In
addition, the ADC value has been shown to be higher in
the white matter compared with the grey matter in the
paediatric brain (21, 22). The ADC values for the white
matter of the centrum semiovale in premature infants
approach 2.0 · 10)3 mm2/s. Thereafter, with increasing
age, the ADC values decrease and the anisotropy values –
especially the RA – increase in a monotonic fashion during
development until they reach the ADC values of the adult
brain (which typically are 0.7 · 10)3 mm2/s) (21, 22). The
changes in ADC values predominantly occur within the
first 6 months of life and are believed to be related to
decreased total water content, myelination, and the
organization of the white matter tracts, which all decrease
the diffusivity (47–49). This value, in turn, changes with
increasing age and when measured in different parts of the
brain (46, 50). Lower FA values have been found in the
frontal white matter in children compared to values found
in young adults suggesting that the measured diffusion
anisotropy is directly related to the maturation of white
matter (51).
Recently, DTI has been used in the evaluation of
normal ageing to detect age-related degeneration (23, 52).
Previous work has shown an age-related ADC elevation in
the cerebral white matter of adults older than 40 years of
age compared with that of younger individuals (53). This
decrease has been shown to occur already after 20 years of
age. A previous study looking at normal ageing found that
diffusion anisotropy, a marker of white matter tract
integrity was reduced in the white matter in older
individuals and fell linearly with increasing age, whereas
the mean diffusitivity was higher in older individuals and
increased with increasing age (54). That study also found
that the increase in anterior mean diffusitivity in the elderly
individuals correlated with executive function. Significant
age-related declines in median FA have been demonstrated
in the anatomically determined areas of densely packed
white matter fibres, especially in genu of corpus callosum
and centrum semiovale (23).
These findings of age-related decrease in white matter
anisotropy suggest that white matter tract disruption occurs
in normal ageing and would be consistent with the cortical
disconnection hypothesis of age-related cognitive decline,
and that it has to be taken into account when evaluating
effects of different diseases, especially in the elderly. An
abnormal decline in FA can be exemplified by a recent
study which showed that, relative to age-matched control
subjects, alcoholic men have lower regional FA values in
the genu of the corpus callosum and in the centrum
semiovale (55).
Another study also demonstrated regional abnormalities
in white matter microstructure, not detectable on conven-
tional MRI in patients with chronic alcoholism (56),
supporting the theory that alcoholism disrupts white matter
microstructure, which contributes to deficits in attention
and working memory.
DTI and diffuse axonal injury
Focal brain injuries other than stroke have not yet been
widely studied with DTI, and it is not fully known whether
mechanisms similar to those reported in ischaemic stroke
are involved in their recovery. The entire mechanisms
underlying the changes in diffusion anisotropy are not yet
fully understood but it has been suggested that they
probably reflect changes in the underlying microscopic
structure of the examined tissue. In ordered structures like
white matter tracts, a loss of order or structural integrity of
the tissue results in a reduction of the FA (33, 57). The
diffusion along axons decreases, while the diffusion in
directions perpendicular increases (58). The traumatic
brain injuries can be classified in two main categories: focal
and diffuse brain injury. The focal brain injury, such as
haematoma and cerebral contusion, results from direct
impact trauma to the head whereas diffuse brain injury
results from shearing injuries and tensile strain on the brain
as a result of abnormal rotation or deceleration of adjacent
tissues that differ in density or rigidity. The resulting tissue
injury is characterized by axonal stretching, disruption,
and eventual separation of nerve fibres (59, 60). It has been
shown that DWI is able to detect additional shearing
injuries not visible on T2 or FLAIR images but also that it
is less sensitive than T2* imaging in detecting hemorrhagic
lesions (61). In that study ADC maps were performed in all
patients and the majority (65%) of the DWI positive lesions
showed decreased diffusion (61). The reduced ADC after
traumatic axonal shearing injury can persist much longer
than is observed with large vessel territorial ischaemia (62).
Surrounding a focal brain lesion such as a contusion or a
focal haematoma, there is zone of apparently ‘tissue at risk’
defined by reduced diffusivity. This apparent zone might
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be of importance in future treatment and in the develop-
ment of new therapies to save this zone in patients with
head trauma (63). Most of the histopathological abnor-
malities seen in diffusion anisotropy values appear to be in
the internal capsule and in the corpus callosum and less in
the grey matter such as thalamus and putamen. A recent
retrospective study of 20 patients with diffuse axonal injury
demonstrated a significant reduction of ADC values within
the splenium of the corpus callosum and significant
reduction of FA values in the internal capsule and spleni-
um of the corpus callosum (58) (Fig. 2). That study also
showed that the correlation between the FA-values and
clinical makers, i.e. GCS/Rankin scores was better than
the correlation between ADC values and clinical markers,
suggesting that FA changes may be able to serve as pre-
dictive parameters for clinical outcome (58).
It has been noted that the significant reduction of
diffusion anisotropy seen in normal appearing white
matter on conventional MRI within the first 24 h after
diffuse axonal injury is less evident, even though still
abnormal, weeks after the trauma (57). A decrease in the
diffusion coefficient has been demonstrated in normal or
almost normal appearing areas on T1, T2 and FLAIR
images already within the first day of life in newborns
with high risk of perinatal brain injury. However, this
decrease in diffusion coefficient became more obvious at
third day of life with a normalization of the values within
a week – so-called pseudonormalization (64). At this point
in time the conventional MRI was abnormal. These
findings suggest that DTI obtained on the first day after
an injury might not show the full extent of the injury in
newborn infant and that images preformed 3 days after
the injury might be better predictors of the final extent of
the injury (64).
Noteworthy is that many of previous studies are small
and limited, and therefore, it is obvious that further
research with larger longitudinal studies and correlation
with pathological specimens and clinical outcome is
needed to fully evaluate the use DTI in the estimation of
the full extent of a brain injury, in the prediction of clinical
outcome, and to find out the optimal timing for the MRI
examination.
DTI in the evaluation of brain tumour
Despite the information provided by conventional MR
with contrast-enhanced T1- and T2-weighted sequences to
characterize the location and extent of the tumour the
radiological specification and grading of a brain tumour is
still limited. Therefore there is a growing interest in the use
DWI and DTI to evaluate different tumour components,
and to differentiate tumour invasion from normal brain
tissue or oedema. ADC maps have proved to be helpful in
defining solid enhancing tumour, no contrast enhancing
lesion, peritumoural oedema, and necrotic and/or cystic
regions from normal surrounding brain tissue (11, 12, 65–
70).
It has been demonstrated that cystic or necrotic regions
have highest ADC values (65) while contrast-enhancing
part of the tumour has lower ADC than both the cystic or
the necrotic areas and oedema (11, 12, 65–70). A recent
study has shown that FA values and histograms of mean
diffusivity in peritumoural areas could not be used to
differentiate high-grade from low-grade gliomas or men-
ingiomas from intraaxial tumours (71). Other recent
studies have demonstrated similar findings with a trend
towards reduction of FA but not of mean diffusitivity in the
peritumoural oedema of glioblastomas compared to men-
ingioma (72) and also alterations in FA in white matter in
the affected as well as in the contralateral hemispheres in
j Fig. 2. Axonal brain injury. A 18-year-old male who was
an unrestrained passenger in a motor vehicle accident.
Small focal areas of slightly increased signal, present in the
white matter of the right frontal lobe and corpus callosum on
T2-weighted (a) and flair (b) images. The diffusion-weighted
images (DWI) demonstrate scattered areas of increased
signal within the right frontal lobe and in the splenium and
body of the corpus callosum as can be seen in axonal
shearing injury and ischaemia (c). The ADC maps show
focal areas of decreased ADC (d) and decreased FA is seen
on the FA map in the same region (e).
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glioblastomas but not in metastases (73). However, signi-
ficant increase in mean diffusivity and significant decrease
in FA have been demonstrated in the peritumoural region
of both gliomas and metastatic tumours when compared
with those of normal appearing white matter (74).
Furthermore, the peritumoural mean diffusivity of meta-
static lesions measured significantly greater than that of
gliomas whereas the FA values showed no discrepancy
between tumour and metastatic lesions, suggesting that the
FA changes in areas surrounding gliomas can be attributed
to both increased water content and tumour infiltration
(74). Such infiltration may result in deviation and disor-
ganization in the white matter as has been seen in
tractography studies (75, 76).
Other measurements such as Tumour Infiltration Index
(TII) have recently been introduced to separate tumours
with presumed purely vasogenic oedema, i.e. metastases
and extra-axial lesions such as meningioma from those
with tumour-infiltrated oedema, i.e. high- and low-grade
glial tumours. The mean TII was significantly higher in
presumed tumour-infiltrated oedema (71).
DWI and DTI both in the adult as well as in the
paediatric population have also been used to explore the
possibility of differentiating the type and the grade of a
tumour. Several studies have shown that low-grade astr-
ocytoma has higher ADC values whereas high-grade
malignant glioma has lower ADC values – findings
reflecting more restricted diffusion with increasing tumour
cellularity (12, 67, 68, 77). However a recent study
concluded that differentiation of tumours by the use of
FA values which are generally reduced in tumours
suggesting structural disorder does not add any additional
information to the tissue differentiation (69), but may help
in the understanding of the effect of brain tumours on
white matter fibres, which may be important in the pre-
surgical planning (76, 78). In a small DTI study four major
patterns have been identified in the affected white matter
tracts, categorized on the basis of anisotropy and fibre
direction or orientation. Such patterns may potentially be
helpful in pre-surgical planning (79) (Fig. 3).
In the treatment of patients with tumour it is crucial to
obtain reliable information about tumour response to
therapy. Recent data from both animal models and human
studies suggest that diffusion imaging may be a sensitive
tool in the evaluation of tumour response to therapy
(80–82) and be helpful in predicting chemosensitivity of
glial tumours (83). Early increasing ADC values during
therapy may relate to therapy-induced cell necrosis. The
subsequent drop in ADC values within the tumour to
pretreatment levels is thought to be an indicator of tumour
(a) (b)
(c) (d)
j Fig. 3. Brain tumour. A 63-year-old
woman with a left frontal astrocytoma.
T1-weighted post-contrast enhanced
images demonstrates pathological
contrast enhancement in the left fron-
tal lobe and the genu of the corpus
callosum (a). The apparent diffusion
coefficient (ADC) was slightly in-
creased compared to normal regions
of the brain (b) and the fractional
anisotropy (FA) value was decreased
(c). The disruption of the white matter
tracts can nicely be seen on the
directional encoded images (DEC) (d).
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re-growth. These findings are in part in contradiction to
results that demonstrate increased ADC values in recurrent
tumours compared to those obtained in patients with
radiation injury/necrosis.
A recent study demonstrated the possibility to use ADC-
maps and relative cerebral blood volume measurements to
evaluate chemosensitivity; areas of the tumour with the
lowest ADC values and highest rCBV demonstrated a
significant volume reduction during treatment whereas
other components of the tumour demonstrated no change
in volume (83).
DTI in the evaluation of radiation injury versus recurrent
tumour
Enhancing lesions that arise on routine follow-up brain
MRI at the site of a previously identified and treated pri-
mary intracranial neoplasm may present a significant
diagnostic dilemma. These lesions are typically subjected
to radiation and/or chemotherapy and in most instances
surgical resection. Many do not have specific imaging
characteristics that enable the neuroradiologist to dis-
criminate tumour recurrence from the inflammatory or
necrotic changes which result from treatment with radi-
ation and/or chemotherapy (84). Both recurrent tumours
and treatment-related changes (i.e. necrosis) typically
demonstrate enhancement with gadolinium and are com-
monly surrounded by an area of increased T2 signal.
However, recent reports have suggested that diffusion
measurements can potentially provide important diagnos-
tic information regarding newly enhancing lesions as well
as of the surrounding areas of signal abnormality that may
appear months to years after radiation therapy in patients
previously treated for primary and metastatic brain tu-
mours (85, 86). We found in a recent study of 19 patients
who presented with a new area of contrast enhancement
at, or nearby, the site of previously treated (surgery/biopsy
and radiation therapy ) neoplasm that the ADC values
were significantly higher in patients with tumour recur-
rence (mean 1.23 · 10)3 mm2/s) than in those with
treatment related changes (mean 1.07 · 10)3 mm2/s)
(Figs 4 and 5). FA values were lower in both groups
compared with FA values in normal appearing frontal
white matter but no statistical difference was seen in the FA
values in the contrast-enhancing lesion between the two
groups (85, unpublished data). Increased ADC values in
recurrent tumours have also been reported by others
(87–89). Contradictions in literature exist regarding the
question whether an increased ADC is to be expected
in tumour or radiation injury/necrosis. In a recent study
the recurrence group showed statistically lower mean
ADC values (mean 1.18 · 10)3 mm2/s) compared with
the treatment-induced necrosis group (mean 1.40 ·
10)3 mm2/s) (86). Also, in another study higher ADC
values were seen in treatment-related changes/radiation
necrosis than in solid tumours (90).
Two recent studies have shown that although the mean
ADC values in areas of T2-prolongation, surrounding the
contrast enhancing lesion differ compared to values
obtained in normal brain tissue no significant differences
are demonstrated between patients with radiation injury
and those with recurrent tumour (86, 91). One of these
studies demonstrated significantly higher ADC ratios
(ADC in abnormal area/ADC in normal appearing brain
tissue) in the oedema in patients with radiation injury
compared to those with tumour recurrence (91). More
interestingly, the same study demonstrated that for the
normal appearing white matter tract adjacent to the
oedema, both the FA values and the FA ratios were
significantly lower in patients with recurrent tumour
compared to those with radiation injury. These findings
may indicate that the DTI provides a helpful method in
detecting occult white matter tract invasion and the FA
measurement could be more sensitive than ADC.
Noteworthy limitations for all these studies are the small
number of patients and the lack of histological confirmation
in all cases. There is certainly a need for further exploration
with larger studies, and correlation with histopathological
specimens and clinical outcome in this field.
DTI and multiple sclerosis
Numerous studies have been published on MRI diffusion
measurements in MS. All studies have shown that the
mean diffusivity is elevated in lesions that are seen on T2-
weighted images. The degree of elevation seems to be
somehow related to the clinical course of the disease. The
lesions with more ‘destructive’ pathology are generally
shown to have the most strongly elevated diffusivity (7, 52,
92–94). An elevated diffusivity (4–13%) has also been
found in normally appearing white matter of MS patients –
this interesting fact may suggest that MS is a diffuse white
matter disease as well as multifocal in nature. On the other
hand those findings also may suggest that the white matter
may be subjected to WD proximal and distal to the visible
lesions (7, 8, 93–95).
In addition, a recent study has demonstrated increased
water diffusivity in the cerebral grey matter of MS patients,
suggesting that the grey matter may not be spared by the
pathological process (96). A recent study assessing the
magnitude of cognitive impairment in patients with
relapsing-remitting MS concluded that moderate correla-
tion of mean ADC and mean FA values seems to reflect the
severity of language, attention, and memory deficits in
these patients (97).
It appears that the FA values are more sensitive than
ADC values in detecting white matter abnormalities in MS
(93, 98, 99). A few studies have demonstrated generally
reduced diffusion anisotropy in MS lesions, in one study
the lowest anisotropy was seen in acute inflammatory
lesions (93) while another study found the lowest aniso-
tropy in T-1 hypointense lesions (94) (Fig. 6).
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DTI and epilepsy
Hippocampal sclerosis is a common cause of refractory
complex partial seizures from the temporal lobes (100).
High resolution MRI has been used in identifying specific
features such as hippocampal volume loss and T2 or
FLAIR signal hyperintensity (101, 102). Recent studies
utilizing DTI in patients with chronic epilepsy and hip-
pocampal sclerosis have demonstrated increased diffusivity
and reduced anisotropy in sclerotic hippocampi, which are
findings suggesting loss of structural organization and
expansion of the extracellular space (103, 104). These
j Fig. 4. Radiation injury. A 42-year-old woman, status post surgery and radiation for an anaplastic oligoastrocytoma with
new contrast enhancing lesions in the left frontal lobe and left aspect of the corpus callosum, as seen on the T1-weighted
post-contrast enhanced image (a). The patient was evaluated for radiation injury versus recurrent tumour and an ROI was
placed over the contrast-enhancing lesion (b). ADC maps (c, d) and FA-maps (e, f) were generated. The ADC value of the
solid lesion was 1.04 · 10)5 mm2/s and the FA ratio of the solid lesion was 0.28.
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changes in diffusivity have shown to extend beyond the
origin of seizure, involving normally appearing brain tissue
(104). There are patients with refractory epilepsy and ex-
tra-temporal, neocortical epilepsy, in which high-resolution
MRI techniques have identified malformations of cortical
development (MCD) as potential epileptogenic foci. Pre-
liminary data in 12 patients with refractory epilepsy and
cortical signal abnormalities showed differences in the
ADC values within the lesion compared to normal brain
tissue in the same location on the contralateral side,
whereas there was a significant overlap between the FA




j Fig. 5. Recurrent tumour. A 37-year-old woman status post-surgery, chemo- and radiation therapy for left frontal
astrocytoma, presenting with new contrast enhancing lesion in the left frontal lobe, as seen on T1-weighted post-contrast
enhanced images (a). The patient was evaluated for radiation injury versus recurrent tumour and an ROI was placed over the
contrast-enhancing lesion (b). ADC maps (c, d) and FA maps (e, f) were generated. The ADC value of the solid lesion was
1.37 · 10)5 mm2/s and the FA ratio of the solid lesion was 0.38.
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demonstrate higher diffusivity and lower anisotropy not
only in the area of MCD but also in surrounding brain
tissue that appeared normal on conventional MRI (106).
Also others have reported similar abnormalities in diffu-
sivity and anisotropy in normally appearing brain tissue
beyond the origin of seizure (107, 108).
A recent study used DTI to study bifrontal schizen-
cephaly and subcortical heterotopia, showing low FA
within the subcortical heterotopia, including that lining the
cleft. The study also demonstrated deviation in the
direction of the corticospinal tracts surrounding the
heterotopic grey matter as compared to normal subjects
and by using fibre tracking the authors could demonstrate
the corticospinal tracts to be smaller and widely separated
from the pyramidal fibres, and also an alteration in white
matter fascicles (109). Other authors have used DTI to
study white matter pathways in band heterotopia (105) and
holoprosencephaly (110).
It is evident that DTI may prove invaluable in
identifying potential epileptogenic foci, in describing
aberrations of white matter fibre tracts as well as in more
precise defining of the extent of lesion for surgical
resection.
DTI and cognitive decline and Alzheimer’s disease
Studies of Alzheimer’s disease (AD) have concentrated on
changes in anisotropy associated with AD progression.
Changes in diffusion anisotropy have been demonstrated
by measuring diffusivity in the corpus callosum at the
midline where axons are primarily oriented in the left–
right direction (111). That study showed that the
anisotropy was decreased in the genu and the splenium of
the corpus callosum in AD patients compared with that of
sex- and age-matched controls, most likely due to axonal
loss or demyelination in these areas (111). In another study
the integrity of axonal tracts in areas associated with cog-
nitive function was compared with this of tracts associated
with motor function (112). By using the lattice index (20) as
a measure of white matter tract integrity, the author’s
demonstrated preservation of the motor tracts but axonal
degeneration in the cognitive tracts (112).
(a) (b)
(c) (d)
j Fig. 6. Multiple sclerosis. A 43-year-old woman with multiple sclerosis. T2-weighted image demonstrates multiple areas
of increased signal representing plaques (a). T1-weighted post-contrast enhanced image (b); none of them demonstrate any
pathological contrast enhancement. These lesions demonstrate increased ADC (c) and decreased (d) FA values.
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DTI has also been used in the evaluation of different
forms of cognitive impairment in patients other than those
with Alzheimer’s disease, such as in adults with reading
difficulties (113), and in detecting degenerated fibre tracts in
the disconnection syndrome (114). A recent investigation
showed decreased diffusion anisotropy bilaterally in the
temporo-parietal white matter in subjects with reading
difficulty (113). That study demonstrated that the white
matter diffusion anisotropy in the temporo-parietal region of
the left hemisphere was significantly correlated with reading
scores within the reading-impaired adults and within the
control group, reflecting the microstructure of white matter
tracts, which may contribute to reading ability (113).
Metabolic disorders
Lately, several reports on DTI in the diagnosis of metabolic
disorders, such as malignant phenylketonuria (PKU) (115),
adrenoleucodystrophy (ALD) (116–118), and Krabbe’s
disease (119), and in the differentiation of dysmyelinating
from the demyelinating disorders (120, 121) have been
published.
A recent study, in which patients with treated chronic
malignant PKU were evaluated, demonstrated significantly
lower FA values in the parieto-occipital and central white
matter in PKU patients older than 3 years and also the
eigenvectors (EV) EV2 and EV3 were significantly larger
than those in the controls, and the findings were, in part,
correlated with IQ (115). In X-linked ALD a decrease in
FA and an increase in ADC have been demonstrated (117,
118): these changes in FA values and ADC within affected
white matter correlate with previously described histopath-
ological zones seen in this disease (122). These findings
suggest an increase in free water and the loss of the
integrity of the myelin sheaths and axons in the white
matter, resulting in increased diffusivity.
Finally, DTI has been found to be superior to conven-
tional MRI in differentiating dysmyelinating disorders,
such as Pelizaeus–Merzbacher disease from demyelinating
disorders, such as Krabbe’s disease and Alexander’s
disease. Diffusional anisotropy remains present in dysmy-
elinated lesions but is lost in demyelinated lesions – findings
verified both in animal and human studies (120, 121).
Conclusion
The recent development of DTI allows direct examination,
in vivo, of some aspects of the brain tissue microstructure.
The use of DTI has already shown to be valuable in
neuroanatomy, fibre connectivity and in examination of
brain development. It has become a highly interesting tool
in the evaluation of different pathological processes in the
brain, such as cerebral ischaemia, traumatic brain injury,
multiple sclerosis, Alzheimer’s disease and cognitive
impairment, epilepsy, brain tumours and metabolic disor-
ders.
However, further improvements in technique and stable
post-processing analyses are needed. There is significant
increase in the utilization of DTI both in research and in
clinical applications.
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